The choreography of neuroinflammation in Huntington's disease

Crotti, Andrea, Glass, Christopher K.·2015·Trends in Immunology
DOI 10.1016/j.it.2015.04.007

Cited by (278)

Items 201–278 of 278

  1. Biphasic Role of Microglia in Healthy and Diseased Brain
    Mohit Kumar, Palkin Arora, Rajat Sandhir · 2022 · Springer eBooks
  2. Contribution of gut microbiota in the pathogenesis of amyotrophic lateral sclerosis and Huntington’s disease
    A. A. Farooqui · 2021 · Elsevier eBooks
  3. Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases
    A. A. Farooqui · 2021 · Elsevier eBooks
  4. Neuroinflammation in Huntington’s Disease
    John D. Lee, Martin W. Lo, Jenny N. Fung, Trent M. Woodruff · 2021 · Neuromethods
  5. Glial Reactivity in Response to Neurotoxins: Relevance and Methods
    Lindsay T. Michalovicz, James Patrick O'Callaghan · 2019 · Neuromethods
  6. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases
    Katherine E. Olson, Rodney Lee Mosley, Howard Eliot Gendelman · 2020 · Springer eBooks
  7. Immunomodulation – a disease‐modifying avenue for treatment of Huntington's disease?
    Maria Björkqvist · 2016 · Journal of Neurochemistry
  8. cGAS, a DNA Sensor, Promotes Inflammatory Responses in Huntington Disease
    Manish Sharma, Sumitha Rajendrarao, Neelam Shahani, Uri Nimrod Ramírez-Jarquín, Srinivasa Subramaniam · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  9. Plant derived bioactive compounds for the treatment of neurodegeneration and neuroimmune disorders associated with the complement system
    Jeyaparthasarathy Narayanaperumal, Ganesh Gopal · 2024 · Exploration of Immunology
  10. Neurodegenerative Disorder: An Overview
    Monika Verma, Sangeeta Shukla, Sadhana Shrivastava, Nidhi Puranik · 2025 · Springer eBooks
  11. Phytomicronutrients in neurodegeneration: modulating microglial dynamics for neuroprotection
    Krishnendu Adhikary, Gari Prameela, Joy Das, Mohhammad Ramzan, Krishnendu Ganguly, Nilanjana Datta, Pradipta Banerjee, Saurav Barman, Sathvik Belagodu Sridhar, Tahreen Taj et al. · 2026 · Zeitschrift für Naturforschung C
  12. Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease
    Birna Ásbjörnsdóttir, Christian Sandøe Musaeus, Marie N.N. Hellem, Tua Vinther‐Jensen, Patrick Ejlerskov, Esben Budtz–Jørgensen, Filippa Liliendahl Qvist, Anja Hviid Simonsen, Lena E. Hjermind, Niels Henning Skotte et al. · 2026 · PLoS ONE
  13. Crosstalk between cytokines and tryptophan metabolism: Therapeutic potential for immune effector cell-associated neurotoxicity syndrome
    Jianghua Wu, Dehu Li, Heng Mei, Yu Hu · 2026 · Biochemical Pharmacology
  14. Targeting the cGAS–STING pathway mitigates Huntington disease pathogenesis in a knock-in mouse model
    Anuradha Kesharwani, Sunayana Dagar, Isabella Zuniga, Marianne C. Monet, Ganesh V. Halade, Gunjan Upadhyay, Uri Nimrod Ramírez-Jarquín, Violeta G. López-Huerta, Emaad Mirza, Ning Quan et al. · 2026 · Proceedings of the National Academy of Sciences
  15. Functional imaging in Huntington disease
    Martin Niethammer, David Eidelberg · 2017 · Handbook of clinical neurology
  16. Huntington’s Disease
    Miroslav Cuturic · 2020 · Springer eBooks
  17. Glial Cells
    Teresa Faria Pais · 2016 · Compendium of Inflammatory Diseases
  18. Inflammation Biomarkers in Huntington’s Disease
    Maria Björkqvist · 2023 · Contemporary clinical neuroscience
  19. Systems biology study of Huntington's disease
    Leonardo E. Dionisio, Peter Langfelder, Jeffrey S. Aaronson, Jim Rosinski, X. William Yang · 2024 · Elsevier eBooks
  20. The Molecular Basis for Protective Effect of Mediterranean Diet in Neurodegenerative Disorders
    Jai Malik, Sunayna Choudhary · 2018 · Elsevier eBooks
  21. PET in Huntington’s Disease
    Hannie Kremer · 2020 · Springer eBooks
  22. Innate immune mechanisms mediate loss of corticostriatal synapses in Huntington’s disease
    2023 · Nature Medicine
  23. Neuroinflammation
    Joseph M. Gullett · 2019 · Springer eBooks
  24. Single-cell variations of circadian clock and immune gene expression in microglia and neurodegeneration
    Koliane Ouk, Müge Yalçın, Ludovica Rigat, Hadas Keren‐Shaul, Eyal David, Anniki Knop, Chotima Böttcher, Achim Kramer, Ido Amit, Angela Relógio et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. PET in Huntington’s Disease
    Hannie Kremer · 2014 · Springer eBooks
  26. Neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
    Vivek Kumar Tripathi, Nihar Ranjan Jana · 2016 · Springer eBooks
  27. Els processos neuroinflamatoris associats a les malalties neurodegeneratives. Si se m’inflama el cervell, se m’oblida el teu nom?
    Francisco Ros‐Bernal · 2016 · Anuari de l'Agrupació Borrianenca de Cultura: revista de recerca humanística i científica
  28. A Genomic Screen of Saccharomyces cerevisiae Reveals a Potential Link Between Nonstop Decay and Autophagy
    Thomas David Daniel Kazmirchuk · 2017
  29. A meta-analysis of transcriptomic profiles from Huntington’s disease patients points to a pathophysiological role of CDC42, NFY, DLX1 and PRMT3
    Manuel Seefelder, Stefan Kochanek · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  30. A Preview of Selected Articles - June 2018
    Stuart P. Atkinson · 2018 · Stem Cells
  31. Neuroinflammation
    Joseph M. Gullett · 2021 · Springer eBooks
  32. A Preview of Selected Articles—July 2021
    Stuart P. Atkinson · 2021 · Stem Cells Translational Medicine
  33. Faculty Opinions recommendation of Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration.
    Xinnan Wang · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  34. Huntington’s Chorea
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  35. Glial Cells
    Teresa Faria Pais · 2015 · Encyclopedia of Inflammatory Diseases
  36. Faculty Opinions recommendation of High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration.
    Sandrine Humbert · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  37. Positron emission tomography imaging of neuroinflammation
    2023 · Advances in magnetic resonance technology and applications
  38. The potential role of herbal medicine and nutraceutical in neuroinflammatory disorders: A mechanistic insight via multisignaling cascades
    Adnan Khan, Bushra Shal, Ashraf Ullah Khan, Hussain Ali, Salman Khan · 2023 · Elsevier eBooks
  39. Associations of Blood Inflammatory Cytokines and Hair Cortisol with Depression Symptoms and Cognitive Functioning in Huntington’s Disease
    Hiba Bilal, Stuart J. McDonald, Julie C. Stout, Ian H. Harding · 2023 · medRxiv
  40. Merkezi Sinir Sisteminde MSS Mikroglia Mast Hücrelerinin Rolü ve Nörodejeneratif Hastalıklar Açısından Önemi
    Tansu KUŞAT, Emrah SUR · 2023
  41. Additional file 9 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Dahyun Yu, Nicole Zarate, Angel White, De’jah Coates, Tsai, Wei, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  42. Neuroinflammation-microglia and neurodegeneration
    Aya M. Fathy, Doaa M. Mostafa, Hanan T. Sedeq, Habiba A. Hassan, Habiba W. Abdullah, Mennatullah M. Fawzy, Majdeldin E. Abdelgilil, Youssef A. Ebrahim, Wael Mohamed El-Sayed · 2024 · Elsevier eBooks
  43. La enfermedad de Huntington como Modelo Paradigmático de Convergencia Neuropsiquiátrica: Implicaciones Clínicas y de Investigación
    Sandra Hernandez Pulido, Daniela Reyes Rojas, Karla Itzel Sánchez Cabrera, Sthepany Briones Rojas · 2025 · Estudios y Perspectivas Revista Científica y Académica
  44. Fatty Acid Profile in the Liver of Mice with Early- and Late-Onset Forms of Huntington’s Disease
    Magdalena Gregorczyk, Adriana Mika, Tomasz Śledziński, Marta Tomczyk, Iwona Rybakowska · 2025 · International Journal of Molecular Sciences
  45. Cognitive Disability and Inflammation in Huntington’s Disease
    Süleyman Serdar Alkanlı, Nevra Alkanlı, Arzu Ay · 2025 · Springer eBooks
  46. Additional file 7 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  47. Additional file 3 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  48. Additional file 10 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  49. Additional file 1 of Parthenolide ameliorates 3-nitropropionic acid-induced Huntington’s disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting
    Mona E Noureldeen, Nancy Nabil Shahin, Amin, Hebat Allah A., El-Sawalhi, Maha M., Heba R. Ghaiad · 2024 · Figshare
  50. Additional file 8 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  51. Additional file 14 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  52. Additional file 13 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  53. Additional file 15 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  54. Additional file 1 of Induced neural stem cell grafts exert neuroprotection through an interaction between Crry and Akt in a mouse model of closed head injury
    Mou Gao, Qin Dong, Wang, Wenjia, Yang, Zhijun, Lili Guo, Yingzhou Lu, Ding, Boyun, Chen, Lihua, Zhang, Jianning, Xu, Ruxiang · 2021 · Figshare
  55. Additional file 12 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  56. Additional file 4 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  57. Additional file 5 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  58. Additional file 6 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  59. Additional file 2 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  60. Additional file 1 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  61. Additional file 16 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  62. Additional file 18 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  63. Additional file 11 of CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease
    Yu, Dahyun, Nicole Zarate, Angel White, De’jah Coates, Wei Tsai, Carmen Nanclares, Francesco Cuccu, Johnny S. Yue, Taylor G. Brown, Rachel H. Mansky et al. · 2022 · Figshare
  64. Evaluation des effets potentiels anti-inflammatoires et neuroprotecteurs d'un agoniste des récepteurs nicotiniques de l'acétylcholine alpha 7 dans un modèle in vivo de neuroinflammation chez le rat
    Laura Foucault‐Fruchard · 2018 · theses.fr (ABES)
  65. Role of the cholesterol hydroxylase enzyme CYP46A1 in cholesterol metabolism and neuroprotection in Huntington's disease
    Radhia Kacher · 2019 · theses.fr (ABES)
  66. Étude de la surexpression du récepteur activé par les proliférateurs de peroxysomes (PPAR) b/d spécifiquement dans les lymphocytes T : effet sur l’inflammation associée à l’obésité et à un choc septique
    Gwenaëlle Le Menn · 2018 · theses.fr (ABES)
  67. Les astrocytes réactifs, des partenaires anti-agrégants dans la maladie de Huntington : identification des mécanismes impliqués dans le dialogue neurone-astrocyte
    Laurene Abjean · 2019 · theses.fr (ABES)
  68. Neuronal and Astrocytic Lipid Metabolic Coupling Mediates Ozone-Induced Learning and Memory Impairment
    Ben Li, Xiaomin Liang, Xue Cui, Wenxu Zhao, J M Xue, Su Wang, T F Liu, Liangpo Liu, Jianquan Guo, Wenping Zhang et al. · 2026 · Environment & Health
  69. Exploration of the genetic neuroinflammatory environment in the human midcingulate cortex in Huntington’s disease
    Mackenzie Wendy Ferguson, Shelley Scheepers, Thulani Hansika Palpagama, Malvindar K. Singh‐Bains, Aodán Laighneach, Derek W. Morris, CLINTON TURNER, Lynette J. Tippett, Henry John Waldvogel, Richard L. M. Faull et al. · 2026 · Communications Medicine
  70. Nanotherapeutics targeting neuroinflammation
    Bivek Chaulagain, Benjamin Tagoe, Avinash Gothwal, Arun Kumar Mahanta, Chinenye Edith Muolokwu, Babita Lamsal, Jagdish Singh · 2026 · Elsevier eBooks
  71. Network-based stratification of allele-specific expression reveals patient subgroups in Huntington’s disease
    D. van Beek, Aishwarya Iyer, Friederike Ehrhart, C. Evelo, Theo M. de Kok, Ilja C. W. Arts, M. Adriaens, Martina Kutmon · 2026 · Bioinformatics
  72. Metals in Huntington's Disease and Other Disorders
    Zahid Ahmad Thoker, Lovleen Marwaha · 2026 · IGI Global eBooks
  73. Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington’s disease progression
    Helga María Grétarsdóttir, Janet L. Cunningham, Annica J. Rasmusson, Joachim Burman, Kim Kultima, Martin Paucar, Per Svenningsson, Radu Constantinescu, Valter Niemelä · 2026 · Journal of Neurology
  74. Plant-derived multitarget therapeutics for Huntington’s disease: A network pharmacology perspective
    Danie J. Kingsley, Danie J. Kingsley · 2026 · South African Journal of Botany
  75. Gene therapy in Huntington’s disease (HD)
    Fatemeh Tirgar, Mina Hosseini, Sakineh Alijanpour, Mohamad-Reza Aghanoori, Sahar Alijanpour, Hami Mahdavinataj · 2026 · Elsevier eBooks
  76. Estrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington’s disease
    John Carlson · 2026 · Neurodegenerative Disease Management
  77. From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease
    Young Cha, Kwang‐Soo Kim · 2026 · Cell Reports Medicine
  78. BindingDB Entry 50012342: GPR52 Antagonist Reduces Huntingtin Levels and Ameliorates Huntington's Disease-Related Phenotypes.
    BindingDB · 2022 · UC San Diego